Archives

Earlier this week Bridge to Life (BTL) became aware of the distribution of a recall notice from Krackeler Southeast Scientific LLC (KSE which was acquired by ILC Dover) to OPO’s. BTL wanted to [...]

Bridge to Life Ltd. announced today its divestiture of certain assets to TransMedics, Inc., a wholly owned subsidiary of TransMedics Group, Inc., including its EVOSS heart and lung and LifeCradle [...]

Bridge to Life Ltd. announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress (ATC).

Bridge to Life, Ltd. announced that it met positive criteria from interim analysis for early enrollment closure of its multicenter, randomized, controlled Bridge to HOPE Liver Clinical Trial.

Bridge to Life, Ltd. announced the expansion of their executive leadership team by appointing Bob Beechey as Chief Financial Officer and Blago Herrera as Vice President of Operations.